Schlumberger Limited (FRA:SCL)

Blueprint Medicines Revenue

Schlumberger had revenue of $8.55B USD in the quarter ending June 30, 2025, a decrease of -6.49%. This brings the company's revenue in the last twelve months to $35.48B, up 0.94% year-over-year. In the year 2024, Schlumberger had annual revenue of $36.29B with 9.52% growth.

• Revenue (ttm): $35.48B
• Revenue Growth: +0.94%
• P/S Ratio: 1.46
• Revenue / Employee: $322.53K
• Employees: 110,000
• Market Cap: 44.08B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	36.29B	3.15B	9.52%
Dec 31, 2023	33.14B	5.04B	17.96%
Dec 31, 2022	28.09B	5.16B	22.51%
Dec 31, 2021	22.93B	-672.00M	-2.85%
Dec 31, 2020	23.60B	-9.32B	-28.30%